Macrophage-targeting nano-formulated bicalutamide alleviates colitis by inducing MAP3K1-mediated degradation of NLRP3

Suqin Zhong(South China University of Technology), Xueqing Yao(Guangdong Academy of Medical Sciences), Yinyin Yang(Guangdong Academy of Medical Sciences), Xiaowan Huang(Dongbei University of Finance and Economics), Youcui Xu(Guangdong Academy of Medical Sciences), Yi Wu(National Science Centre), Zhiyuan Liu(Jiangsu Province Hospital), Shanshan Li(Guangdong Academy of Medical Sciences), Yangyang Zhu(Guangdong Academy of Medical Sciences), Xinfeng Wang(South China University of Technology), Suzhen Zhong(Guangdong General Hospital), Yu Wu(National Science Centre), Zhengang Zhou(Guangdong Academy of Medical Sciences), Longping Wen(Guangdong Academy of Medical Sciences)
Journal of Controlled Release
February 10, 2025
Cited by 3


Related Papers